Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhG-CSF Injection Regimen in Breast Cancer Chemotherapy
NCT04477616Phase 2Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jul 2021
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in febrile neutropenia (FN), neutropenia, sponsored by Jiangsu Provincial People's Hospital. Started Jul 2021; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
febrile neutropenia (FN)neutropenia
Beyond the preview
Go deeper on NCT04477616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04477616.